ArticleAnimal models and experimental medicine2026
The characteristics of collagen-induced rheumatoid arthritis in macaques and the changes of heart.
Article in Animal models and experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundBased on human Rheumatoid Arthritis (RA) criteria, this study established a macaque collagen-induced arthritis (CIA) model and a standardized non-human primate (NHP) standardized diagnostic framework. Integrating these tools, we characterized three disease stages (IIR, e-RA, a-RA) and key early biomarkers, thereby providing a robust platform for investigating RA pathogenesis research and conducting preclinical evaluation of humanized macromolecular drugs.
methodsCIA was induced in macaques via through immunization with bovine type II collagen emulsified in complete Freund's adjuvant. Disease progression was monitored using multimodal imaging (MRI, CT, X-ray, and ultrasonography), enabling comprehensive assessment of joint edema, vascularity, bone erosion, and cardiopulmonary function.
resultsThe disease progression in CIA macaques was categorized into three stages: IIR (days 14-34), e-RA (days 35-41), and a-RA (days 42-70). Notably, bone erosion progressed independently of the resolution of joint swelling resolution, with a trend toward aggravated severity during the post-swelling phase. Furthermore, cardiac assessments demonstrated that valvular damage primarily affected the tricuspid valve, with more pronounced impairment of right ventricular diastolic function. Additionally, observed pulmonary inflammation suggests potential lung involvement, though its progression throughout the disease course requires further investigation.
conclusionsThe progression of CIA in macaques can be divided into three stages: IIR (14-34 days), e-RA (35-41 days), and a-RA (42-70 days). For RA patients, bone erosion should be prioritized in clinical monitoring, and cardiac assessment should focus on the tricuspid valve and right ventricular diastolic function.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.